Werum Software & Systems, a provider of Manufacturing Execution Systems for the pharmaceutical and biotech industries, is expanding its business footprint in the Asia-Pacific region by founding subsidiaries in Japan and Singapore.
With Japan as the second largest pharmaceutical market in the world, and emerging markets such as India and China, Werum expects the Asia-Pacific countries to be of growing relevance for its MES business. “Many of our large multinational customers with operations in Asia-Pacific as well as local manufacturers will improve their manufacturing quality and drug safety in order to meet international standards,” said Hartmut Krome, chairman of Werum's executive board. “Our MES product PAS-X will be the key for such improvements. We expect future growth in the Asia-Pacific region to contribute a rapidly increasing share, with Japan and Singapore as the focal points of the business.”
Werum’s new subsidiaries in Japan and Singapore will reinforce the local support capacities that the company already provides in cooperation with its established solution partners in Japan, Singapore, Thailand, China, and Australia.